Literature DB >> 31356980

Infratentorial Glioblastoma Metastasis to Bone.

Jocelyn A Ricard1, Samuel W Cramer2, River Charles3, Carolina Gil Tommee3, An Le3, W Robert Bell3, Clark C Chen2, Margaret E Flanagan3.   

Abstract

BACKGROUND: Glioblastoma multiforme (GBM) is a rapid-growing central nervous system neoplasm. We report a case of GBM with extensive intramedullary lumbar drop metastasis and highly unusual osseous spine metastasis from a primary infratentorial GBM occurring 10 years after the initial diagnosis, which to our knowledge has not been described previously. CASE DESCRIPTION: This 37-year-old man presented with new-onset headaches of increasing severity. Brain magnetic resonance imaging (MRI) demonstrated a heterogeneously enhancing mass in the left superior temporal lobe with adjacent edema. The lesion was initially biopsied in December 2006 and diagnosed as GBM (World Health Organization grade IV) with characteristic features of a highly cellular infiltrating glial neoplasm with nuclear pleomorphism, abundant microvascular proliferation, and abundant necrosis with pseudopalisading nuclei. Ki-67 immunostaining revealed that 15%-20% tumor cell nuclei were positive, indicating a high proliferative index. Histologically, this neoplasm demonstrated characteristic "cell wrapping." Immunoreactivity was variably but strongly positive for glial fibrillary acidic protein in neoplastic cells. In 2018, additional MRI revealed disease throughout the spine and bone biopsy of the thoracic spine showed the same glial neoplasm with primitive neuroectodermal tumor-like components (GBM-PNET).
CONCLUSIONS: This case is meant to highlight that, although rare, infratentorial GBM-PNET has a higher frequency of isocitrate dehydrogenase 1 (IDH1) mutation and may metastasize to the spine years after the initial diagnosis despite the likely better prognosis.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glioblastoma multiforme; Isocitrate dehydrogenase (IDH1/IDH2); Metastasis; Spine

Mesh:

Substances:

Year:  2019        PMID: 31356980     DOI: 10.1016/j.wneu.2019.07.142

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  4 in total

Review 1.  Bone metastasis from glioblastoma: a systematic review.

Authors:  Michael J Strong; Sravanthi Koduri; Jodi A Allison; Cecilia M Pesavento; Sebele Ogunsola; Oludotun Ogunsola; Timothy J Yee; Siri Sahib S Khalsa; Yamaan S Saadeh; Jacob R Joseph; Osama N Kashlan; Paul Park; Mark E Oppenlander; Nicholas J Szerlip
Journal:  J Neurooncol       Date:  2022-05-17       Impact factor: 4.130

2.  A Rare Manifestation of a Presumed Non-Osteophilic Brain Neoplasm: Extensive Axial Skeletal Metastases From Glioblastoma With Primitive Neuronal Components.

Authors:  Tianhua Rong; Wanjing Zou; Xiaoguang Qiu; Wei Cui; Duo Zhang; Bingxuan Wu; Zhuang Kang; Wenbin Li; Baoge Liu
Journal:  Front Oncol       Date:  2021-11-02       Impact factor: 6.244

Review 3.  Tumor-Derived Exosomes Modulate Primary Site Tumor Metastasis.

Authors:  Suwen Bai; Zunyun Wang; Minghua Wang; Junai Li; Yuan Wei; Ruihuan Xu; Juan Du
Journal:  Front Cell Dev Biol       Date:  2022-03-02

Review 4.  Cytology of Extraneural Metastases of Nonhematolymphoid Primary Central Nervous System Tumors: Six Cases with Histopathological Correlation and Literature Update.

Authors:  Joerg Schwock; Lorna Mirham; Zeina Ghorab
Journal:  Acta Cytol       Date:  2021-07-26       Impact factor: 2.319

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.